Tamoore Arshad
Overview
Explore the profile of Tamoore Arshad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arshad T, Vainer D, Khan H, Baral A, Garg S, Ang A, et al.
Dig Dis Sci
. 2024 Mar;
69(5):1844-1851.
PMID: 38499735
Introduction: Vibration-controlled transient elastography (VCTE) based liver stiffness measurement (LSM) is an excellent 'rule-out' test for advanced hepatic fibrosis in liver transplant (LT) recipients, however, its ability to 'rule-in' the...
2.
Fan R, Yu N, Li G, Arshad T, Liu W, Wong G, et al.
Liver Int
. 2023 Dec;
44(3):749-759.
PMID: 38131420
Background & Aims: aMAP score, as a hepatocellular carcinoma risk score, is proven to be associated with the degree of chronic hepatitis B-related liver fibrosis. We aimed to evaluate the...
3.
Fan R, Li G, Yu N, Chang X, Arshad T, Liu W, et al.
Clin Gastroenterol Hepatol
. 2023 Mar;
21(12):3070-3079.e13.
PMID: 36933605
Background & Aims: The changes in liver stiffness measurement (LSM) are unreliable to estimate regression of fibrosis during antiviral treatment for chronic hepatitis B (CHB) patients. The age-male-albumin-bilirubin-platelets score (aMAP),...
4.
Arshad T, Bhati C, Bui A, Tseng M, Vainer D, Miller A, et al.
Liver Transpl
. 2022 Aug;
29(2):196-205.
PMID: 36036790
Combining bioclinical parameters with liver stiffness measurement (LSM) has improved the diagnostic performance of vibration-controlled transient elastography (VCTE) for detection of advanced fibrosis in patients with chronic liver disease. However,...
5.
Tseng M, Connelly M, Vanier D, Arshad T, Kirkman D, Siddiqui M
Clin Gastroenterol Hepatol
. 2022 May;
21(6):1660-1662.e1.
PMID: 35533996
No abstract available.
6.
Alqahtani S, Paik J, Biswas R, Arshad T, Henry L, Younossi Z
Hepatol Commun
. 2021 Sep;
5(11):1833-1847.
PMID: 34558829
Population-based studies that estimate awareness of nonalcoholic fatty liver disease (NAFLD) in the United States are scant. We aimed to understand public awareness of NAFLD and its temporal trends. Our...
7.
Arshad T, Paik J, Biswas R, Alqahtani S, Henry L, Younossi Z
Hepatol Commun
. 2021 Sep;
5(10):1676-1688.
PMID: 34558817
Understanding the burden of NAFLD among adolescents and young adults has become increasingly relevant. Our aim was to estimate the prevalence of NAFLD among adolescents and young adults in the...
8.
Pasala S, Singer L, Arshad T, Roach K
IDCases
. 2020 Oct;
22:e00915.
PMID: 33088710
Lactobacilli are commensal anaerobic gram-positive rod organisms that are normal flora of the oral, genitourinary, and gastrointestinal tracts. is now commonly found in probiotics. They are rarely pathogenic, but occasional...
9.
Golabi P, Paik J, Arshad T, Younossi Y, Mishra A, Younossi Z
Hepatol Commun
. 2020 Aug;
4(8):1136-1148.
PMID: 32766474
Although nonalcoholic fatty liver disease (NAFLD) is associated with obesity, it can also occur in lean and metabolically normal individuals. Our aim was to determine the effect of different combinations...
10.
Sayiner M, Arshad T, Golabi P, Paik J, Farhat F, Younossi Z
Hepatol Int
. 2020 Apr;
14(4):556-566.
PMID: 32300995
Background And Aim: Non-alcoholic fatty liver disease (NAFLD) is a very common liver disease which has been associated with a number of the extrahepatic manifestations (EHMs) and healthcare expenditures. Our...